Infectious Disease In Vitro Diagnostics Advancing Early Detection And Clinical Decision Support
The increasing burden of infectious diseases across the globe continues to place significant pressure on healthcare systems, driving the demand for accurate, rapid, and scalable diagnostic solutions. In vitro diagnostics (IVD) has emerged as a cornerstone of modern healthcare, enabling early detection, disease monitoring, and effective treatment planning. With advancements in biotechnology, molecular diagnostics, and automation, infectious disease diagnostics are undergoing rapid transformation. The global infectious disease in vitro diagnostics market size was estimated at USD 24.30 billion in 2024 and is projected to reach USD 28.05 billion by 2030, growing at a CAGR of 2.5% from 2025 to 2030. The growing geriatric population susceptible to infectious diseases, rising awareness about early testing, high demand for PoC testing owing to the pandemic, and rising prevalence of infectious diseases are key factors driving the market over the forecast period. This growth r...